Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial Complex I, specifically the PSST subunit-associated site, is a critical component of the mitochondrial electron transport chain responsible for the oxidation of NADH and the reduction of ubiquinone (UniProt: P48764). The PSST subunit (NDUFS7) is a core, highly conserved protein that contributes to the formation of the ubiquinone-binding pocket (Q-site) and houses the N2 iron-sulfur cluster, the final electron donor in the complex's electron transfer chain (PubMed: 15544951). In the context of viable cardiomyocytes, this site is a key target for pharmacological intervention to mitigate ischemia-reperfusion injury by reducing the burst of reactive oxygen species (ROS) upon reperfusion (PubMed: 22303013). Drugs like metformin are thought to interact with this region to mildly and reversibly inhibit complex I activity, which provides cardioprotective effects and activates the AMPK pathway (PubMed: 24509906). Beyond cardioprotection, the PSST subunit is clinically significant as mutations in the NDUFS7 gene are a known cause of Leigh syndrome, a severe neurodegenerative disorder characterized by mitochondrial dysfunction (PubMed: 11431143). This site is also the target of classic inhibitors such as rotenone and piericidin A, which are used extensively in biochemical research to study mitochondrial respiration.
Reversible inhibition of the ubiquinone-binding site (Q-site) of Mitochondrial Complex I, which prevents the transfer of electrons from the N2 iron-sulfur cluster to ubiquinone, thereby modulating the proton motive force and reducing the production of reactive oxygen species.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit S7 (NDUFS7) (NDUFS7).